These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3870879)

  • 21. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy.
    Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA
    J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of the mode of action of antitumour triazenes and triazines--IV. The metabolism of 1-(4-acetylphenyl)-3,3-dimethyltriazene.
    Farina P; Gescher A; Hickman JA; Horton JK; D'Incalci M; Ross D; Stevens MF; Torti L
    Biochem Pharmacol; 1982 May; 31(10):1887-92. PubMed ID: 7104021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic evaluation of some N-acyl and N-acyloxy analogues of 3,5-bis(arylidene)-4-piperidones.
    Dimmock JR; Arora VK; Chen M; Allen TM; Kao GY
    Drug Des Discov; 1994 Jul; 12(1):19-28. PubMed ID: 7578805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential anticancer agents. XXII. Pharmacological properties of some new triazene derivatives.
    Ionescu D; Neagu V; Dobre V; Niculescu-Duvaz I
    Neoplasma; 1981; 28(1):19-26. PubMed ID: 7279057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumour prodrug development using cytochrome P450 (CYP) mediated activation.
    Patterson LH; McKeown SR; Robson T; Gallagher R; Raleigh SM; Orr S
    Anticancer Drug Des; 1999 Dec; 14(6):473-86. PubMed ID: 10834269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antitumor activities of amino acid prodrugs of amino-combretastatins.
    Ohsumi K; Hatanaka T; Nakagawa R; Fukuda Y; Morinaga Y; Suga Y; Nihei Y; Ohishi K; Akiyama Y; Tsuji T
    Anticancer Drug Des; 1999 Dec; 14(6):539-48. PubMed ID: 10834274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of 4-nitro-substituted 1,3-diaryltriazenes as a novel class of potent antitumor agents.
    Cimbora-Zovko T; Brozovic A; Piantanida I; Fritz G; Virag A; Alič B; Majce V; Kočevar M; Polanc S; Osmak M
    Eur J Med Chem; 2011 Jul; 46(7):2971-83. PubMed ID: 21550697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antiproliferative activity of O-silylated nucleoside triazene N-oxide derivatives.
    Tronchet JM; Grivet C; Grand E; Seman M; Dilda P
    Carbohydr Lett; 2000; 4(1):5-12. PubMed ID: 11469337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-Substituted 2-(2,6-dinitrophenylamino)propanamides: novel prodrugs that release a primary amine via nitroreduction and intramolecular cyclization.
    Sykes BM; Atwell GJ; Hogg A; Wilson WR; O'Connor CJ; Denny WA
    J Med Chem; 1999 Feb; 42(3):346-55. PubMed ID: 9986704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine- and tyramine-based derivatives of triazenes: activation by tyrosinase and implications for prodrug design.
    Perry MJ; Mendes E; Simplício AL; Coelho A; Soares RV; Iley J; Moreira R; Francisco AP
    Eur J Med Chem; 2009 Aug; 44(8):3228-34. PubMed ID: 19386398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
    Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective tumor targeting by the hypoxia-activated prodrug AQ4N blocks tumor growth and metastasis in preclinical models of pancreatic cancer.
    Lalani AS; Alters SE; Wong A; Albertella MR; Cleland JL; Henner WD
    Clin Cancer Res; 2007 Apr; 13(7):2216-25. PubMed ID: 17404106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prodrugs of thymidylate synthase inhibitors: potential for antibody directed enzyme prodrug therapy (ADEPT).
    Springer CJ; Bavetsias V; Jackman AL; Boyle FT; Marshall D; Pedley RB; Bisset GM
    Anticancer Drug Des; 1996 Dec; 11(8):625-36. PubMed ID: 9022750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
    ter Haar E; Day BW
    Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological characterization of a novel antitumor quinolone.
    Clement JJ; Burres N; Jarvis K; Chu DT; Swiniarski J; Alder J
    Cancer Res; 1995 Feb; 55(4):830-5. PubMed ID: 7850797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
    Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
    Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel fluorinated prodrugs for activation by carboxypeptidase G2 showing good in vivo antitumor activity in gene-directed enzyme prodrug therapy.
    Davies LC; Friedlos F; Hedley D; Martin J; Ogilvie LM; Scanlon IJ; Springer CJ
    J Med Chem; 2005 Aug; 48(16):5321-8. PubMed ID: 16078849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs.
    Wu W; Borch RF
    Mol Pharm; 2006; 3(4):451-6. PubMed ID: 16889439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.